본문으로 건너뛰기
← 뒤로

TGF-β, to target or not to target; to prevent thyroid cancer progression?

1/5 보강
Biochimica et biophysica acta. Reviews on cancer 📖 저널 OA 2.4% 2022: 0/2 OA 2023: 0/1 OA 2024: 1/4 OA 2025: 0/39 OA 2026: 2/77 OA 2022~2026 2022 Vol.1877(4) p. 188752
Retraction 확인
출처

Karnik I, Sutherland R, Elson J, Aspinall S, Meeson A

📝 환자 설명용 한 줄

Thyroid cancer (TC) is a common endocrine cancer with a rising incidence.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Karnik I, Sutherland R, et al. (2022). TGF-β, to target or not to target; to prevent thyroid cancer progression?. Biochimica et biophysica acta. Reviews on cancer, 1877(4), 188752. https://doi.org/10.1016/j.bbcan.2022.188752
MLA Karnik I, et al.. "TGF-β, to target or not to target; to prevent thyroid cancer progression?." Biochimica et biophysica acta. Reviews on cancer, vol. 1877, no. 4, 2022, pp. 188752.
PMID 35728736 ↗

Abstract

Thyroid cancer (TC) is a common endocrine cancer with a rising incidence. Current treatment fails to eliminate aggressive thyroid tumours, prompting an investigation into the processes that cause disease progression. In this review, we provide insight into TGF-β driven epithelial to mesenchymal transition (EMT), summarizing the current literature surrounding thyroid carcinogenesis, and discuss the potential for therapeutic strategies targeting the TGF-β signalling pathway. Understanding the underlying mechanisms that regulate cancer stem cell (CSC) growth and TGF-β signalling may provide novel therapeutic approaches for highly resistant TCs.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반